A transgenic mouse model of metastatic prostate cancer originating from neuroendocrine cells.
about
Loss of Nkx3.1 leads to the activation of discrete downstream target genes during prostate tumorigenesisPim1 kinase synergizes with c-MYC to induce advanced prostate carcinomaInhibition of cell growth by EGR-1 in human primary cultures from malignant gliomaRebuilding cancer metastasis in the mouseA mouse stromal response to tumor invasion predicts prostate and breast cancer patient survivalConditional loss of Nkx3.1 in adult mice induces prostatic intraepithelial neoplasiaRevealing the large-scale network organization of growth hormone-secreting cells.Matrix metalloproteinases contribute distinct roles in neuroendocrine prostate carcinogenesis, metastasis, and angiogenesis progressionMouse models of prostate cancer.An integrated functional genomics and metabolomics approach for defining poor prognosis in human neuroendocrine cancers.Mouse models of prostate cancer: picking the best model for the question.Slug inhibits proliferation of human prostate cancer cells via downregulation of cyclin D1 expression.Transforming functions of Simian Virus 40.Linkage between cellular communications, energy utilization, and proliferation in metastatic neuroendocrine cancersDevelopment of PIN and prostate adenocarcinoma cell lines: a model system for multistage tumor progressionA fluorescence-coupled assay for gamma aminobutyric acid (GABA) reveals metabolic stress-induced modulation of GABA content in neuroendocrine cancer.Deregulated expression of insulin-like growth factor 1 in prostate epithelium leads to neoplasia in transgenic mice.Models of metastatic prostate cancer: a transgenic perspective.Conditional expression of the androgen receptor induces oncogenic transformation of the mouse prostate.Neoplastic disorders of prostate glands in the light of synchrotron radiation and multivariate statistical analysis.Simian virus 40 transformation, malignant mesothelioma and brain tumors.A graphical user interface for a comparative anatomy information system: design, implementation and usage scenarios.Prostatic intraepithelial neoplasia in genetically engineered miceA neuroendocrine/small cell prostate carcinoma xenograft-LuCaP 49Neuroendocrine Tumors of the Prostate: Emerging Insights from Molecular Data and Updates to the 2016 World Health Organization Classification.Genetically engineered murine models of prostate cancer: insights into mechanisms of tumorigenesis and potential utility.Advances in mouse models of prostate cancer.Maternal high-fat diet induces hyperproliferation and alters Pten/Akt signaling in prostates of offspring.Is EGR1 a potential target for prostate cancer therapy?Transgenic Mouse Studies to Understand the Regulation, Expression and Function of the Testis-Specific Protein Y-Encoded (TSPY) Gene.RNA interference of achaete-scute homolog 1 in mouse prostate neuroendocrine cells reveals its gene targets and DNA binding sites.Genetically modified mouse models of cancer invasion and metastasis.Proliferative and nonproliferative lesions of the rat and mouse male reproductive system.Modeling prostate cancer in mice: something old, something new, something premalignant, something metastatic.The role of murine models of prostate cancer in drug target discovery and validation.Current mouse and cell models in prostate cancer research.EGR1 target genes in prostate carcinoma cells identified by microarray analysis.De novo large cell neuroendocrine carcinoma of the prostate gland with pelvic lymph node metastasis: a case report with review of literature.Drug discovery in prostate cancer mouse models.Morphoregulatory pathways in prostate ductal development.
P2860
Q24314483-DF3FDDE1-2338-4746-9105-6B3811D769B9Q24630639-77CA201A-8C12-4EE1-97D8-FB62B9946E06Q24791972-692CFDFB-E34A-4639-A028-D31676238DBDQ26864450-A4B082D6-211F-4036-BC02-3515918F7AE8Q27303204-FDC3C2C2-1F49-462A-BBD6-09E54B9F8964Q28587079-FBFCB375-0F28-4FFE-8E72-7128AB3EF0B7Q30476345-C9589F48-374C-4BAF-9531-16E3F926E6D1Q33732496-812C4BE7-C97C-4E7B-9BD8-D2B424D24F9CQ33739296-FDCF5DAF-6987-45B9-B17F-37C780368E07Q33885324-0592936F-E8F8-495A-A81A-085C17427DF5Q33940867-06AE20A0-BCC5-4DED-BE93-6A4A6CC12E42Q34148084-F11E550D-B0B9-4662-8DA5-B1734442C635Q34468794-6A2C0E06-BC18-42E7-A0CF-046B81BAFA33Q34945291-C2A8CD82-19EB-4B2C-818A-297D7D428C8CQ34997451-A69393D0-6375-433A-8FC2-80DE802D4CA6Q35097478-B0DA9360-6C14-413F-947E-CA10E2F4F43EQ35112453-248FDBA2-DE5E-408A-B380-489DC520E83DQ35217386-A254B082-FFDC-4E59-9047-CAFFC952D8EAQ35312172-0B8D0952-A020-4ADB-B472-5D4EA8DB6F88Q35564161-5F3F2845-AE97-45C8-8AC1-945857C33D40Q35621800-63265AC0-6C25-4AC5-8BB5-D15A28C9B71AQ35727925-565CC437-8C29-4FD7-8B42-9DA557C3DEC8Q35747658-1E6BA602-638F-44E8-9653-9D9446652EC0Q35747677-2D10F88A-71CF-4C6C-AC7B-7468F6FA3806Q35925835-7B89DB99-1EAF-41DE-BA6F-4434BF110364Q36429488-8107A721-042D-4CE7-986A-B927929C60DFQ37185527-16DE04BE-86CE-4EBA-B2AA-5149A1695372Q37379265-6BE4679F-77C1-4ED9-86B4-B4B238C0792CQ37418513-A33BEECB-13F0-4AB3-97C2-AB6CF1A08A28Q37637016-D1B31454-1237-45F5-B845-81AF8A1386ECQ37682012-15191FA4-2621-4B1B-A517-F5B23CCF7946Q38009316-E5F172EB-1AFC-4BCA-A1AB-EB1B02C355CCQ38040759-4928649F-1F18-4399-ABE0-B7B9FD6691F9Q38056848-1E517A72-7730-4283-B44D-2626602FDCF6Q38089910-229AB09B-447C-4CCC-B575-9E2EC0E8059CQ38098499-C1711AE2-84AE-49F9-83F2-22B90D6BC113Q38308423-396AD642-B84A-4F6F-97C6-390D77BE0676Q38352504-5F531332-BEFF-4BAF-89EC-32E0CFFA314FQ38509211-E14E1C24-C2DC-485C-A330-D53BB3E57D37Q39018865-9418FF3E-1583-4968-9353-D83AAC310A6B
P2860
A transgenic mouse model of metastatic prostate cancer originating from neuroendocrine cells.
description
1998 nî lūn-bûn
@nan
1998 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
A transgenic mouse model of me ...... ing from neuroendocrine cells.
@ast
A transgenic mouse model of me ...... ing from neuroendocrine cells.
@en
A transgenic mouse model of me ...... ing from neuroendocrine cells.
@nl
type
label
A transgenic mouse model of me ...... ing from neuroendocrine cells.
@ast
A transgenic mouse model of me ...... ing from neuroendocrine cells.
@en
A transgenic mouse model of me ...... ing from neuroendocrine cells.
@nl
prefLabel
A transgenic mouse model of me ...... ing from neuroendocrine cells.
@ast
A transgenic mouse model of me ...... ing from neuroendocrine cells.
@en
A transgenic mouse model of me ...... ing from neuroendocrine cells.
@nl
P2093
P2860
P356
P1476
A transgenic mouse model of me ...... ing from neuroendocrine cells.
@en
P2093
E M Garabedian
J I Gordon
P A Humphrey
P2860
P304
15382-15387
P356
10.1073/PNAS.95.26.15382
P407
P577
1998-12-01T00:00:00Z